The annual Controlling Cancer Summit was an international academic event which discussed current research and thinking regarding screening, prevention and treatment in this ever-growing field. Presenting at this event, were a variety of clinicians, academics and members of the pharmaceutical industry.
Congratulations to our prize winners
Poster prize winners
Dr An Ning Cheng (NHRI, Taiwan)
PHOSPHORYLATION OF HSP90 BY CDC7-DBF4 PROMOTES HR REPAIR AND CELL SURVIVAL IN ORAL CANCER
Mrs Barbara Wyroba (Jagiellonian University Poland)
ROLE OF ADAM17 IN TUMOR INVASION AND METASTASIS OF A MELANOMA CELL LINE IN MURINE AND ZEBRAFISH MODELS
Rebecca Kan
THE EFFECTS OF IKKB-SPECIFIC INHIBITOR PS1145 ON TUMOR FORMATION IN NASOPHARYNGEAL CARCINOMA
Feedback prize winner
Dr Mark Eccleston (VolitionRx, UK)
-
- Poster prize winner, Dr An Ning Cheng (NHRI, Taiwan) with Dr Nikolaos Georgopoulos (University of Huddersfield, UK).
-
- Poster prize winner Mrs Barbara Wyroba (Jagiellonian University Poland) and Dr Jing Jie Yu (West Virginia University, USA).
-
- Feedback winner Dr Mark Eccleston (VolitionRx, UK) and Professor Rui Amaral Mendes (CaseWEstern Reserve Univresity, Ohio, USA)
Advancing Pathology for Cancer Diagnosis, Staging and Prognosis 2017
will take place on the 16th – 18th May 2017
www.lifescienceevents.com/Cancer2017
